Scientific work

Doç. Dr. Nalan Akgül Babacan

63 publications. The source of the information is stated next to each publication.

Back to profile

  1. Telli, T. A., Demircan, N. C., Alan, O., Tuylu, T. B., Arikan, R., Ercelep, O., R Ergelen, IE Seven, NA Babacan ... & Kaya, S. (2020). A rare case of primary rectal choriocarcinoma and review of the literature. Journal of Oncology Pharmacy Practice, 26(4), 989-994.

    Source: medicana.com.tr profile page

  2. Ercelep, O., Alan, O., Telli, T. A., Tuylu, T. B., Arıkan, R., Demircan, N. C., ET Simsek, NA Babacan ... & Bozkurtlar, E. (2020). Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori Journal, 0300891620950475.

    Source: medicana.com.tr profile page

  3. Alan, O., Telli, T. A., Tuylu, T. B., Arikan, R., Demircan, N. C., Ercelep, O., S Kaya, NA Babacan ... & Bayri, Y. (2020). Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience. Journal of Oncology Pharmacy Practice, 1078155220920684.

    Source: medicana.com.tr profile page

  4. Robinson, L. A., Babacan, N. A., Tanvetyanon, T., Henderson-Jackson, E., Bui, M. M., & Druta, M. (2020). Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas. The Journal of Thoracic and Cardiovascular Surgery.

    Source: medicana.com.tr profile page

  5. Babacan, N. A., & Eroglu, Z. (2020). Treatment options for advanced melanoma after anti-PD-1 therapy. Current Oncology Reports, 22(4), 1-8.

    Source: medicana.com.tr profile page

  6. Babacan, N. A., Peguero, E., Forsyth, P., & Eroglu, Z. (2021). BRAF Inhibitor Therapy‐Related Encephalitis in a Patient with Metastatic Melanoma. The Oncologist, 26(10), e1887-e1889.

    Source: medicana.com.tr profile page

  7. Alan, O., Telli, T. A., Tuylu, T. B., Arikan, R., Demircan, N. C., Ercelep, O., Kaya, S., Babacan, N.A., Atasoy, B.M., Bozkurt, S. Bayri, Y.& Yumuk, P. F. (2021). Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience. Journal of Oncology Pharmacy Practice, 27(2), 329-339.

    Source: medicana.com.tr profile page

  8. Ercelep, O., Alan, O., Telli, T. A., Tuylu, T. B., Arıkan, R., Demircan, N. C., Simsek, E.T., Babacan, N.A., Kaya, S., Dane, F., Bozkurtlar, E. & Yumuk, P. F. (2021). Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori Journal, 107(3), 231-237.

    Source: medicana.com.tr profile page

  9. Yildiz, F., Demirci, U., Küçükarda, A., Büyüksimsek, M., Sakalar, T., Topcu, T. O., Aslan, F., Tufan, G., Aydin, O., Turna, H. Babacan, N.A., Paydas, S. (2021). Merkel cell carcinoma in Turkey: A multicentric study. Journal of cancer research and therapeutics, 17(6), 1525.

    Source: medicana.com.tr profile page

  10. Alan, O., Telli, T. A., Tuylu, T. B., Arikan, R., Demircan, N. C., Ercelep, O., Kaya, S., Babacan, N.A., Atasoy, B.M., Bozkurt, S. and Bayri, Y., Yumuk, P. F. (2021). Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience. Journal of Oncology Pharmacy Practice, 27(2), 329-339.

    Source: medicana.com.tr profile page

  11. Bahar-Ozdemir, Yeliz, Sefik Kaya, Nalan Akgul Babacan, Tugce Al, Ece Albayrak, Nilufer Coskun, and Gulseren Akyuz. "Can assessment of disease burden and quality of life based on mobility level in patients with end-stage cancer provide an insight into unmet needs? An exploratory cross-sectional study." Physiotherapy Theory and Practice (2022): 1-11.

    Source: medicana.com.tr profile page

  12. Eroglu Z, Broman KK, Thompson JF,...Nalan Akgul Babacan, Younchul Kim, Mahrukh Naqvi, Jonathan Zager, Nikhil I Khushalani. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection Journal for ImmunoTherapy of Cancer 2022;10:e004417. doi: 10.1136/jitc-2021-004417

    Source: medicana.com.tr profile page

  13. Akin Telli, T., Ozturk, M.A., Alan, O., Hasanov, R., Kostek, O., Arikan, R., Basoglu, T., Kaya, S., Ercelep, O., Akgul Babacan, N. and Dane, F., 2022. Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy. Future Oncology, 18(22), pp.2425-2439.

    Source: medicana.com.tr profile page